LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 0.9165 | 0.0157 | 0.9003 | 0.0187 |
BT-20 | Linsitinib | 0.37 | uM | LJP5 | 0.9552 | 0.0343 | 0.9489 | 0.0407 |
BT-20 | Linsitinib | 1.11 | uM | LJP5 | 0.9348 | 0.0269 | 0.9239 | 0.0310 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 0.9114 | 0.0251 | 0.8955 | 0.0289 |
BT-20 | Linsitinib | 10 | uM | LJP5 | 0.8312 | 0.0264 | 0.7966 | 0.0292 |
BT-20 | Ruxolitinib | 0.04 | uM | LJP5 | 0.9752 | 0.0321 | 0.9727 | 0.0382 |
BT-20 | Ruxolitinib | 0.12 | uM | LJP5 | 0.9497 | 0.0104 | 0.9416 | 0.0109 |
BT-20 | Ruxolitinib | 0.37 | uM | LJP5 | 0.9563 | 0.0227 | 0.9501 | 0.0264 |
BT-20 | Ruxolitinib | 1.11 | uM | LJP5 | 0.9782 | 0.0402 | 0.9730 | 0.0461 |
BT-20 | Ruxolitinib | 3.33 | uM | LJP5 | 0.9440 | 0.0427 | 0.9330 | 0.0500 |
BT-20 | Ruxolitinib | 10 | uM | LJP5 | 0.7635 | 0.0306 | 0.7073 | 0.0428 |
BT-20 | Momelotinib | 0.04 | uM | LJP5 | 0.9373 | 0.0349 | 0.9261 | 0.0414 |
BT-20 | Momelotinib | 0.12 | uM | LJP5 | 0.8920 | 0.0198 | 0.8711 | 0.0222 |
BT-20 | Momelotinib | 0.37 | uM | LJP5 | 0.8649 | 0.0400 | 0.8372 | 0.0477 |
BT-20 | Momelotinib | 1.11 | uM | LJP5 | 0.7929 | 0.0250 | 0.7475 | 0.0267 |
BT-20 | Momelotinib | 3.33 | uM | LJP5 | 0.6635 | 0.0399 | 0.5757 | 0.0422 |
BT-20 | Momelotinib | 10 | uM | LJP5 | 0.3397 | 0.0348 | 0.0633 | 0.0595 |
BT-20 | Fedratinib | 0.04 | uM | LJP5 | 1.0373 | 0.0158 | 1.0423 | 0.0168 |
BT-20 | Fedratinib | 0.12 | uM | LJP5 | 0.9741 | 0.0046 | 0.9693 | 0.0056 |
BT-20 | Fedratinib | 0.37 | uM | LJP5 | 0.9433 | 0.0126 | 0.9341 | 0.0128 |
BT-20 | Fedratinib | 1.11 | uM | LJP5 | 0.8520 | 0.0188 | 0.8229 | 0.0176 |
BT-20 | Fedratinib | 3.33 | uM | LJP5 | 0.7028 | 0.0194 | 0.6294 | 0.0138 |
BT-20 | Fedratinib | 10 | uM | LJP5 | 0.2367 | 0.0342 | -0.1411 | 0.0802 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 0.7653 | 0.0212 | 0.7101 | 0.0267 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 0.8178 | 0.0274 | 0.7802 | 0.0280 |